Vienna - Delayed Quote EUR

Amplifon S.p.A. (AMP.VI)

18.72
-0.50
(-2.60%)
At close: May 9 at 3:30:22 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,409,241
2,409,241
2,260,084
2,119,126
1,948,075
Cost of Revenue
1,045,406
1,045,406
990,216
943,777
854,223
Gross Profit
1,363,835
1,363,835
1,269,868
1,175,349
1,093,852
Operating Expense
1,110,545
1,110,545
1,019,227
908,186
849,987
Operating Income
253,290
253,290
250,641
267,163
243,865
Net Non Operating Interest Income Expense
-57,062
-57,062
-48,511
-32,480
-29,245
Pretax Income
196,780
196,780
209,747
243,736
223,360
Tax Provision
51,210
51,210
54,722
64,956
59,762
Net Income Common Stockholders
145,374
145,374
155,139
178,525
157,785
Diluted NI Available to Com Stockholders
145,374
145,374
155,139
178,525
157,785
Basic EPS
0.69
0.64
0.69
0.80
0.70
Diluted EPS
0.69
0.64
0.69
0.79
0.69
Basic Average Shares
225,322.87
225,791.95
223,912.79
224,363.32
224,823.93
Diluted Average Shares
226,827.23
226,388.62
225,462.66
226,845.50
227,326.77
Total Operating Income as Reported
256,814
256,814
259,212
278,669
246,000
Rent Expense Supplemental
19,656
19,656
15,936
12,490
10,800
Total Expenses
2,155,951
2,155,951
2,009,443
1,851,963
1,704,210
Net Income from Continuing & Discontinued Operation
145,374
145,374
155,139
178,525
157,785
Normalized Income
143,173.95
143,173.95
147,575
170,124.09
162,124.31
Interest Income
3,878
3,878
2,077
598
198
Interest Expense
57,756
57,756
44,622
30,688
27,677
Net Interest Income
-57,062
-57,062
-48,511
-32,480
-29,245
EBIT
254,536
254,536
254,369
274,424
251,037
EBITDA
557,254
557,254
522,006
514,465
473,458
Reconciled Cost of Revenue
1,045,406
1,045,406
990,216
943,777
854,223
Reconciled Depreciation
302,718
302,718
267,637
240,041
222,421
Net Income from Continuing Operation Net Minority Interest
145,374
145,374
155,139
178,525
163,540
Total Unusual Items Excluding Goodwill
2,974
2,974
10,234
11,461
1,934
Total Unusual Items
2,974
2,974
10,234
11,461
1,934
Normalized EBITDA
554,280
554,280
511,772
503,004
471,524
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
773.95
773.95
2,670
3,060.09
518.31
12/31/2021 - 9/21/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0401.HK WANJIA GROUP
0.070
+2.94%
 
NVLG.TA Novolog (Pharm-Up 1966) Ltd
155.70
+1.24%
 
ARJO-B.ST Arjo AB (publ)
31.08
+1.37%
 
GALE.SW Galenica AG
87.05
+0.12%
 
SIG.AX Sigma Healthcare Limited
3.0200
+0.33%
 
ZYXI Zynex, Inc.
2.0700
-2.36%
 
COSM Cosmos Health Inc.
0.4200
-2.51%
 
8403.TWO ShareHope Medicine Co., Ltd.
28.70
+0.70%
 
4164.TW CHC Healthcare Group
42.65
-0.12%
 
4104.TW Excelsior Medical Co., Ltd.
88.70
-0.34%